Scribd Logo
Upload

Welcome to Scribd!

  • AstraZeneca Information Center Email April 5 2013 About Subjects in Study 41

    Uploaded by

    MarkingsonCase
    29 views1 page
    Response from AstraZeneca to query from Mike Howard asking whether all Study 41 sites enrolled subjects

    Original Title

    AstraZeneca Information Center Email April 5 2013 about subjects in Study 41

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Response from AstraZeneca to query from Mike Howard asking whether all Study 41 sites enrolled subjects

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    29 views1 page

    AstraZeneca Information Center Email April 5 2013 About Subjects in Study 41

    Uploaded by

    MarkingsonCase
    Response from AstraZeneca to query from Mike Howard asking whether all Study 41 sites enrolled subjects

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Dear Mike Howard, Thank you for contacting AstraZeneca regarding A Multicenter, Double-blind, Randomized Comparison of the Efficacy

    and Safety of Sustained-release Formulation Quetiapine Fumarate and Placebo in the Treatment of Patients With Schizophrenia. Study code 5077IL/0041. This study was conducted at 49 centers in the United States(45) and Canada(4), and there were subjects enrolled at each center. Sincerely,

    Information Center at AstraZeneca

    You might also like